In gallbladder cancer, TOP2A promotes cell proliferation and metastasis through the activation of the PI3K/Akt/mTOR signaling pathway, suggesting that it could serve as a therapeutic target (24). This evidence concerns the gene MTOR and gallbladder cancer.